PD-1 and PD-L1 Monoclonal Antibody Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of PD-1 and PD-L1 Monoclonal Antibody in global, including the following market information:
Global PD-1 and PD-L1 Monoclonal Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PD-1 and PD-L1 Monoclonal Antibody Market Sales, 2017-2022, 2023-2028, (Units)
Global top five PD-1 and PD-L1 Monoclonal Antibody companies in 2021 (%)
The global PD-1 and PD-L1 Monoclonal Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD-1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD-1 and PD-L1 Monoclonal Antibody include Merk, Bristol-Myers Squibb Company, Roche, Pfizer, AstraZeneca, Junshi Biosciences, Innovent, Hengrui and BeiGene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-1 and PD-L1 Monoclonal Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-1 and PD-L1 Monoclonal Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, by Type, 2021 (%)
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, by Application, 2021 (%)
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies PD-1 and PD-L1 Monoclonal Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PD-1 and PD-L1 Monoclonal Antibody revenues share in global market, 2021 (%)
Key companies PD-1 and PD-L1 Monoclonal Antibody sales in global market, 2017-2022 (Estimated), (Units)
Key companies PD-1 and PD-L1 Monoclonal Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global PD-1 and PD-L1 Monoclonal Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PD-1 and PD-L1 Monoclonal Antibody Market Sales, 2017-2022, 2023-2028, (Units)
Global top five PD-1 and PD-L1 Monoclonal Antibody companies in 2021 (%)
The global PD-1 and PD-L1 Monoclonal Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD-1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD-1 and PD-L1 Monoclonal Antibody include Merk, Bristol-Myers Squibb Company, Roche, Pfizer, AstraZeneca, Junshi Biosciences, Innovent, Hengrui and BeiGene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD-1 and PD-L1 Monoclonal Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD-1 and PD-L1 Monoclonal Antibody Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, by Type, 2021 (%)
- PD-1
- PD-L1
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, by Application, 2021 (%)
- Lung Cancer
- Liver Cancer
- Esophageal Cancer
- Gastric Cancer
- Nasopharyngeal Carcinoma
- Head and Neck Cancer
- Other
Global PD-1 and PD-L1 Monoclonal Antibody Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies PD-1 and PD-L1 Monoclonal Antibody revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PD-1 and PD-L1 Monoclonal Antibody revenues share in global market, 2021 (%)
Key companies PD-1 and PD-L1 Monoclonal Antibody sales in global market, 2017-2022 (Estimated), (Units)
Key companies PD-1 and PD-L1 Monoclonal Antibody sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merk
- Bristol-Myers Squibb Company
- Roche
- Pfizer
- AstraZeneca
- Junshi Biosciences
- Innovent
- Hengrui
- BeiGene
- Alphamab Oncology
- Cstone
- Akeso
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 PD-1 and PD-L1 Monoclonal Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PD-1 AND PD-L1 MONOCLONAL ANTIBODY OVERALL MARKET SIZE
2.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size: 2021 VS 2028
2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top PD-1 and PD-L1 Monoclonal Antibody Players in Global Market
3.2 Top Global PD-1 and PD-L1 Monoclonal Antibody Companies Ranked by Revenue
3.3 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Companies
3.4 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Companies
3.5 Global PD-1 and PD-L1 Monoclonal Antibody Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PD-1 and PD-L1 Monoclonal Antibody Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 PD-1 and PD-L1 Monoclonal Antibody Players in Global Market
3.8.1 List of Global Tier 1 PD-1 and PD-L1 Monoclonal Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 PD-1 and PD-L1 Monoclonal Antibody Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Market Size Markets, 2021 & 2028
4.1.2 PD-1
4.1.3 PD-L1
4.2 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue & Forecasts
4.2.1 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2022
4.2.2 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2023-2028
4.2.3 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
4.3 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales & Forecasts
4.3.1 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2022
4.3.2 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2023-2028
4.3.3 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
4.4 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Market Size, 2021 & 2028
5.1.2 Lung Cancer
5.1.3 Liver Cancer
5.1.4 Esophageal Cancer
5.1.5 Gastric Cancer
5.1.6 Nasopharyngeal Carcinoma
5.1.7 Head and Neck Cancer
5.1.8 Other
5.2 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue & Forecasts
5.2.1 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2022
5.2.2 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2023-2028
5.2.3 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
5.3 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales & Forecasts
5.3.1 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2022
5.3.2 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2023-2028
5.3.3 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
5.4 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Market Size, 2021 & 2028
6.2 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue & Forecasts
6.2.1 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2022
6.2.2 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2023-2028
6.2.3 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
6.3 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales & Forecasts
6.3.1 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2022
6.3.2 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2023-2028
6.3.3 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.4.2 By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.4.3 US PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.4.4 Canada PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.4.5 Mexico PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.5.2 By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.5.3 Germany PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.4 France PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.5 U.K. PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.6 Italy PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.7 Russia PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.8 Nordic Countries PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.9 Benelux PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.6.2 By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.6.3 China PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.4 Japan PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.5 South Korea PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.6 Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.7 India PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.7.2 By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.7.3 Brazil PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.7.4 Argentina PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.8.3 Turkey PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8.4 Israel PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8.5 Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8.6 UAE PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merk
7.1.1 Merk Corporate Summary
7.1.2 Merk Business Overview
7.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.1.5 Merk Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Junshi Biosciences
7.6.1 Junshi Biosciences Corporate Summary
7.6.2 Junshi Biosciences Business Overview
7.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.6.5 Junshi Biosciences Key News
7.7 Innovent
7.7.1 Innovent Corporate Summary
7.7.2 Innovent Business Overview
7.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.7.5 Innovent Key News
7.8 Hengrui
7.8.1 Hengrui Corporate Summary
7.8.2 Hengrui Business Overview
7.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.8.5 Hengrui Key News
7.9 BeiGene
7.9.1 BeiGene Corporate Summary
7.9.2 BeiGene Business Overview
7.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.9.5 BeiGene Key News
7.10 Alphamab Oncology
7.10.1 Alphamab Oncology Corporate Summary
7.10.2 Alphamab Oncology Business Overview
7.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.10.5 Alphamab Oncology Key News
7.11 Cstone
7.11.1 Cstone Corporate Summary
7.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Business Overview
7.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.11.5 Cstone Key News
7.12 Akeso
7.12.1 Akeso Corporate Summary
7.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Business Overview
7.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.12.5 Akeso Key News
8 GLOBAL PD-1 AND PD-L1 MONOCLONAL ANTIBODY PRODUCTION CAPACITY, ANALYSIS
8.1 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity, 2017-2028
8.2 PD-1 and PD-L1 Monoclonal Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global PD-1 and PD-L1 Monoclonal Antibody Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PD-1 AND PD-L1 MONOCLONAL ANTIBODY SUPPLY CHAIN ANALYSIS
10.1 PD-1 and PD-L1 Monoclonal Antibody Industry Value Chain
10.2 PD-1 and PD-L1 Monoclonal Antibody Upstream Market
10.3 PD-1 and PD-L1 Monoclonal Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PD-1 and PD-L1 Monoclonal Antibody Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 PD-1 and PD-L1 Monoclonal Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PD-1 and PD-L1 Monoclonal Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PD-1 AND PD-L1 MONOCLONAL ANTIBODY OVERALL MARKET SIZE
2.1 Global PD-1 and PD-L1 Monoclonal Antibody Market Size: 2021 VS 2028
2.2 Global PD-1 and PD-L1 Monoclonal Antibody Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PD-1 and PD-L1 Monoclonal Antibody Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top PD-1 and PD-L1 Monoclonal Antibody Players in Global Market
3.2 Top Global PD-1 and PD-L1 Monoclonal Antibody Companies Ranked by Revenue
3.3 Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Companies
3.4 Global PD-1 and PD-L1 Monoclonal Antibody Sales by Companies
3.5 Global PD-1 and PD-L1 Monoclonal Antibody Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PD-1 and PD-L1 Monoclonal Antibody Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 PD-1 and PD-L1 Monoclonal Antibody Players in Global Market
3.8.1 List of Global Tier 1 PD-1 and PD-L1 Monoclonal Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 PD-1 and PD-L1 Monoclonal Antibody Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Market Size Markets, 2021 & 2028
4.1.2 PD-1
4.1.3 PD-L1
4.2 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue & Forecasts
4.2.1 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2022
4.2.2 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2023-2028
4.2.3 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
4.3 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales & Forecasts
4.3.1 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2022
4.3.2 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2023-2028
4.3.3 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
4.4 By Type - Global PD-1 and PD-L1 Monoclonal Antibody Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Market Size, 2021 & 2028
5.1.2 Lung Cancer
5.1.3 Liver Cancer
5.1.4 Esophageal Cancer
5.1.5 Gastric Cancer
5.1.6 Nasopharyngeal Carcinoma
5.1.7 Head and Neck Cancer
5.1.8 Other
5.2 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue & Forecasts
5.2.1 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2022
5.2.2 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2023-2028
5.2.3 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
5.3 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales & Forecasts
5.3.1 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2022
5.3.2 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2023-2028
5.3.3 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
5.4 By Application - Global PD-1 and PD-L1 Monoclonal Antibody Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Market Size, 2021 & 2028
6.2 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue & Forecasts
6.2.1 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2022
6.2.2 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2023-2028
6.2.3 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
6.3 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales & Forecasts
6.3.1 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2022
6.3.2 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales, 2023-2028
6.3.3 By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.4.2 By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.4.3 US PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.4.4 Canada PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.4.5 Mexico PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.5.2 By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.5.3 Germany PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.4 France PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.5 U.K. PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.6 Italy PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.7 Russia PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.8 Nordic Countries PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.5.9 Benelux PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.6.2 By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.6.3 China PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.4 Japan PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.5 South Korea PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.6 Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.6.7 India PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.7.2 By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.7.3 Brazil PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.7.4 Argentina PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales, 2017-2028
6.8.3 Turkey PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8.4 Israel PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8.5 Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
6.8.6 UAE PD-1 and PD-L1 Monoclonal Antibody Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Merk
7.1.1 Merk Corporate Summary
7.1.2 Merk Business Overview
7.1.3 Merk PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.1.4 Merk PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.1.5 Merk Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.2.4 Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.3.4 Roche PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.4.4 Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 AstraZeneca
7.5.1 AstraZeneca Corporate Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.5.4 AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.5.5 AstraZeneca Key News
7.6 Junshi Biosciences
7.6.1 Junshi Biosciences Corporate Summary
7.6.2 Junshi Biosciences Business Overview
7.6.3 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.6.4 Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.6.5 Junshi Biosciences Key News
7.7 Innovent
7.7.1 Innovent Corporate Summary
7.7.2 Innovent Business Overview
7.7.3 Innovent PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.7.4 Innovent PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.7.5 Innovent Key News
7.8 Hengrui
7.8.1 Hengrui Corporate Summary
7.8.2 Hengrui Business Overview
7.8.3 Hengrui PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.8.4 Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.8.5 Hengrui Key News
7.9 BeiGene
7.9.1 BeiGene Corporate Summary
7.9.2 BeiGene Business Overview
7.9.3 BeiGene PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.9.4 BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.9.5 BeiGene Key News
7.10 Alphamab Oncology
7.10.1 Alphamab Oncology Corporate Summary
7.10.2 Alphamab Oncology Business Overview
7.10.3 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.10.4 Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.10.5 Alphamab Oncology Key News
7.11 Cstone
7.11.1 Cstone Corporate Summary
7.11.2 Cstone PD-1 and PD-L1 Monoclonal Antibody Business Overview
7.11.3 Cstone PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.11.4 Cstone PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.11.5 Cstone Key News
7.12 Akeso
7.12.1 Akeso Corporate Summary
7.12.2 Akeso PD-1 and PD-L1 Monoclonal Antibody Business Overview
7.12.3 Akeso PD-1 and PD-L1 Monoclonal Antibody Major Product Offerings
7.12.4 Akeso PD-1 and PD-L1 Monoclonal Antibody Sales and Revenue in Global (2017-2022)
7.12.5 Akeso Key News
8 GLOBAL PD-1 AND PD-L1 MONOCLONAL ANTIBODY PRODUCTION CAPACITY, ANALYSIS
8.1 Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity, 2017-2028
8.2 PD-1 and PD-L1 Monoclonal Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global PD-1 and PD-L1 Monoclonal Antibody Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PD-1 AND PD-L1 MONOCLONAL ANTIBODY SUPPLY CHAIN ANALYSIS
10.1 PD-1 and PD-L1 Monoclonal Antibody Industry Value Chain
10.2 PD-1 and PD-L1 Monoclonal Antibody Upstream Market
10.3 PD-1 and PD-L1 Monoclonal Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PD-1 and PD-L1 Monoclonal Antibody Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of PD-1 and PD-L1 Monoclonal Antibody in Global Market
Table 2. Top PD-1 and PD-L1 Monoclonal Antibody Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Companies, 2017-2022
Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Companies, (Units), 2017-2022
Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type
Table 9. List of Global Tier 1 PD-1 and PD-L1 Monoclonal Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PD-1 and PD-L1 Monoclonal Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2017-2022
Table 15. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2023-2028
Table 16. By Application – Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2017-2022
Table 20. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2023-2028
Table 21. By Region – Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2017-2022
Table 25. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2023-2028
Table 26. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 29. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 30. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 33. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 34. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 37. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 38. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 41. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 46. Merk Corporate Summary
Table 47. Merk PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 48. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Bristol-Myers Squibb Company Corporate Summary
Table 50. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 51. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 54. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 57. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 60. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Junshi Biosciences Corporate Summary
Table 62. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 63. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Innovent Corporate Summary
Table 65. Innovent PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 66. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Hengrui Corporate Summary
Table 68. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 69. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. BeiGene Corporate Summary
Table 71. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 72. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Alphamab Oncology Corporate Summary
Table 74. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 75. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Cstone Corporate Summary
Table 77. Cstone PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 78. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Akeso Corporate Summary
Table 80. Akeso PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 81. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. PD-1 and PD-L1 Monoclonal Antibody Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 83. Global PD-1 and PD-L1 Monoclonal Antibody Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global PD-1 and PD-L1 Monoclonal Antibody Production by Region, 2017-2022 (Units)
Table 85. Global PD-1 and PD-L1 Monoclonal Antibody Production by Region, 2023-2028 (Units)
Table 86. PD-1 and PD-L1 Monoclonal Antibody Market Opportunities & Trends in Global Market
Table 87. PD-1 and PD-L1 Monoclonal Antibody Market Drivers in Global Market
Table 88. PD-1 and PD-L1 Monoclonal Antibody Market Restraints in Global Market
Table 89. PD-1 and PD-L1 Monoclonal Antibody Raw Materials
Table 90. PD-1 and PD-L1 Monoclonal Antibody Raw Materials Suppliers in Global Market
Table 91. Typical PD-1 and PD-L1 Monoclonal Antibody Downstream
Table 92. PD-1 and PD-L1 Monoclonal Antibody Downstream Clients in Global Market
Table 93. PD-1 and PD-L1 Monoclonal Antibody Distributors and Sales Agents in Global Market
Table 1. Key Players of PD-1 and PD-L1 Monoclonal Antibody in Global Market
Table 2. Top PD-1 and PD-L1 Monoclonal Antibody Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PD-1 and PD-L1 Monoclonal Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PD-1 and PD-L1 Monoclonal Antibody Revenue Share by Companies, 2017-2022
Table 5. Global PD-1 and PD-L1 Monoclonal Antibody Sales by Companies, (Units), 2017-2022
Table 6. Global PD-1 and PD-L1 Monoclonal Antibody Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PD-1 and PD-L1 Monoclonal Antibody Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers PD-1 and PD-L1 Monoclonal Antibody Product Type
Table 9. List of Global Tier 1 PD-1 and PD-L1 Monoclonal Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PD-1 and PD-L1 Monoclonal Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2017-2022
Table 15. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2023-2028
Table 16. By Application – Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2017-2022
Table 20. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2023-2028
Table 21. By Region – Global PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2017-2022
Table 25. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales (Units), 2023-2028
Table 26. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 29. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 30. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 33. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 34. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 37. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 38. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 41. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales, (Units), 2023-2028
Table 46. Merk Corporate Summary
Table 47. Merk PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 48. Merk PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Bristol-Myers Squibb Company Corporate Summary
Table 50. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 51. Bristol-Myers Squibb Company PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 54. Roche PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 57. Pfizer PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 60. AstraZeneca PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Junshi Biosciences Corporate Summary
Table 62. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 63. Junshi Biosciences PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Innovent Corporate Summary
Table 65. Innovent PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 66. Innovent PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Hengrui Corporate Summary
Table 68. Hengrui PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 69. Hengrui PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. BeiGene Corporate Summary
Table 71. BeiGene PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 72. BeiGene PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Alphamab Oncology Corporate Summary
Table 74. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 75. Alphamab Oncology PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Cstone Corporate Summary
Table 77. Cstone PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 78. Cstone PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Akeso Corporate Summary
Table 80. Akeso PD-1 and PD-L1 Monoclonal Antibody Product Offerings
Table 81. Akeso PD-1 and PD-L1 Monoclonal Antibody Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. PD-1 and PD-L1 Monoclonal Antibody Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 83. Global PD-1 and PD-L1 Monoclonal Antibody Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global PD-1 and PD-L1 Monoclonal Antibody Production by Region, 2017-2022 (Units)
Table 85. Global PD-1 and PD-L1 Monoclonal Antibody Production by Region, 2023-2028 (Units)
Table 86. PD-1 and PD-L1 Monoclonal Antibody Market Opportunities & Trends in Global Market
Table 87. PD-1 and PD-L1 Monoclonal Antibody Market Drivers in Global Market
Table 88. PD-1 and PD-L1 Monoclonal Antibody Market Restraints in Global Market
Table 89. PD-1 and PD-L1 Monoclonal Antibody Raw Materials
Table 90. PD-1 and PD-L1 Monoclonal Antibody Raw Materials Suppliers in Global Market
Table 91. Typical PD-1 and PD-L1 Monoclonal Antibody Downstream
Table 92. PD-1 and PD-L1 Monoclonal Antibody Downstream Clients in Global Market
Table 93. PD-1 and PD-L1 Monoclonal Antibody Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. PD-1 and PD-L1 Monoclonal Antibody Segment by Type
Figure 2. PD-1 and PD-L1 Monoclonal Antibody Segment by Application
Figure 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PD-1 and PD-L1 Monoclonal Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. PD-1 and PD-L1 Monoclonal Antibody Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by PD-1 and PD-L1 Monoclonal Antibody Revenue in 2021
Figure 9. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 10. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 11. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit), 2017-2028
Figure 12. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 13. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 14. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit), 2017-2028
Figure 15. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 16. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 17. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 18. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 19. US PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 24. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. France PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 33. China PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. India PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 39. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 40. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 44. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 48. Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production PD-1 and PD-L1 Monoclonal Antibody by Region, 2021 VS 2028
Figure 50. PD-1 and PD-L1 Monoclonal Antibody Industry Value Chain
Figure 51. Marketing Channels
Figure 1. PD-1 and PD-L1 Monoclonal Antibody Segment by Type
Figure 2. PD-1 and PD-L1 Monoclonal Antibody Segment by Application
Figure 3. Global PD-1 and PD-L1 Monoclonal Antibody Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PD-1 and PD-L1 Monoclonal Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PD-1 and PD-L1 Monoclonal Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. PD-1 and PD-L1 Monoclonal Antibody Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by PD-1 and PD-L1 Monoclonal Antibody Revenue in 2021
Figure 9. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 10. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 11. By Type - Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit), 2017-2028
Figure 12. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 13. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 14. By Application - Global PD-1 and PD-L1 Monoclonal Antibody Price (US$/Unit), 2017-2028
Figure 15. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 16. By Region - Global PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 17. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 18. By Country - North America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 19. US PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 24. Germany PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. France PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 33. China PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. India PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 39. By Country - South America PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 40. Brazil PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PD-1 and PD-L1 Monoclonal Antibody Sales Market Share, 2017-2028
Figure 44. Turkey PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PD-1 and PD-L1 Monoclonal Antibody Revenue, (US$, Mn), 2017-2028
Figure 48. Global PD-1 and PD-L1 Monoclonal Antibody Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production PD-1 and PD-L1 Monoclonal Antibody by Region, 2021 VS 2028
Figure 50. PD-1 and PD-L1 Monoclonal Antibody Industry Value Chain
Figure 51. Marketing Channels
